T0	KEYPHRASE-NOTYPES 4 11	patient,"One","in "
T1	KEYPHRASE-NOTYPES 20 35	treatment group,"ach","had"
T2	KEYPHRASE-NOTYPES 40 58	objective evidence,"had","of "
T3	KEYPHRASE-NOTYPES 62 74	Lyme disease," of","at "
T4	KEYPHRASE-NOTYPES 82 97	last evaluation,"the","(i."
T5	KEYPHRASE-NOTYPES 105 114	treatment,"e.,","fai"
T6	KEYPHRASE-NOTYPES 126 133	patient,". A","in "
T7	KEYPHRASE-NOTYPES 141 158	ceftriaxone group,"the","who"
T8	KEYPHRASE-NOTYPES 178 205	seventh-cranial-nerve palsy,"ith","and"
T9	KEYPHRASE-NOTYPES 210 224	normal results,"and","on "
T10	KEYPHRASE-NOTYPES 228 243	lumbar puncture," on","con"
T11	KEYPHRASE-NOTYPES 262 267	palsy,"ave","at "
T12	KEYPHRASE-NOTYPES 275 296	three-month follow-up,"the","and"
T13	KEYPHRASE-NOTYPES 311 322	ceftriaxone,"ven","for"
T14	KEYPHRASE-NOTYPES 346 351	weeks,"ive"," De"
T15	KEYPHRASE-NOTYPES 361 370	treatment,"ite"," th"
T16	KEYPHRASE-NOTYPES 376 381	palsy,"the","per"
T17	KEYPHRASE-NOTYPES 398 412	second patient,"n a"," la"
T18	KEYPHRASE-NOTYPES 414 435	large-joint arthritis,"nt,","dev"
T19	KEYPHRASE-NOTYPES 453 462	treatment,"ing","wit"
T20	KEYPHRASE-NOTYPES 468 479	doxycycline,"ith"," th"
T21	KEYPHRASE-NOTYPES 486 493	patient,"his","als"
T22	KEYPHRASE-NOTYPES 503 510	fatigue,"had"," jo"
T23	KEYPHRASE-NOTYPES 528 538	limitation,"ng,","of "
T24	KEYPHRASE-NOTYPES 542 556	joint movement," of"," ar"
T25	KEYPHRASE-NOTYPES 558 568	arthralgia,"nt,"," an"
T26	KEYPHRASE-NOTYPES 574 581	myalgia,"and"," he"
T27	KEYPHRASE-NOTYPES 608 631	intravenous ceftriaxone,"ved","for"
T28	KEYPHRASE-NOTYPES 642 647	weeks,"ree","and"
T29	KEYPHRASE-NOTYPES 658 677	complete resolution,"d a","of "
T30	KEYPHRASE-NOTYPES 685 690	signs,"all","and"
T31	KEYPHRASE-NOTYPES 695 703	symptoms,"and",""
